CDYKS provides insight into the world of Cancer. This site is dedicated to providing insight into what is Cancer,
what are the current treatments, what innovative treatments are emerging in Cancer research.
what are the current treatments, what innovative treatments are emerging in Cancer research.
Let’s start with simple definitions and cancer trends in the United States:
What is Cancer? Cancer is defined as abnormal cells that grow out of control and can spread (metastasis) to other
parts of the body. Metastasis occurs through blood and the lymph system.
What is Oncology? Oncology is the discipline of medicine dedicated to the study of cancer. In the United States,
nonmelanoma skin cancer, lung cancer, breast cancer, prostate cancer, colorectal cancer are some of the most
common cancers. Multiple myeloma, Leukemia, kidney cancer, brain cancer, cancer of the Endocrine system, and
male breast cancer are less common. For more detailed information on cancer and oncology see the following
sites: cancer.net, cancer.gov, cancer.org.
What is Cancer? Cancer is defined as abnormal cells that grow out of control and can spread (metastasis) to other
parts of the body. Metastasis occurs through blood and the lymph system.
What is Oncology? Oncology is the discipline of medicine dedicated to the study of cancer. In the United States,
nonmelanoma skin cancer, lung cancer, breast cancer, prostate cancer, colorectal cancer are some of the most
common cancers. Multiple myeloma, Leukemia, kidney cancer, brain cancer, cancer of the Endocrine system, and
male breast cancer are less common. For more detailed information on cancer and oncology see the following
sites: cancer.net, cancer.gov, cancer.org.
Cancer prevention (Insight):
Did you know that cancer is a preventable disease? Approximately, 2/3 of cancers deaths could be prevented by
lifestyle changes. Cancer deaths correlate with diet, lack of exercise, tobacco, alcohol use, sun exposure. Lifestyle
changes can decrease the likelihood of developing cancer.
Did you know that cancer is a preventable disease? Approximately, 2/3 of cancers deaths could be prevented by
lifestyle changes. Cancer deaths correlate with diet, lack of exercise, tobacco, alcohol use, sun exposure. Lifestyle
changes can decrease the likelihood of developing cancer.
Cancer Insights at CDYKS.com
Listed below are recent, innovative cancer therapies and details of the intend
use:
Tykerb was approved by FDA March 13, 2007 and developed by GlaxoSmithKline. It is a recently approved theraypy
indicated in combination with Xeloda® for the treatment of patients with advanced or metastatic breast cancer
whose tumors overexpress HER2 and who have received prior therapy including the following: anthracycline, taxane,
and Herceptin® .
Gleevec was developed by Novartis and was approved in 2001 by the FDA. It was the first of a new class of targeted
cancer therapies for certain types of cancer. Gleevec is targeted therapy for treating chronic myelogenous leukemia
(CML), gastrointestinal stromal tumor (GIST), and other malignancies. In particular, it targets, and turns off (inhibits),
specific proteins in cancer cells that prevent cancer cells from growing and multiplying.
Abraxane was approved by the FDA on January 7, 2005 and was developed by AM Bioscience. It is an intended
therapy for breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6
months of adjuvant chemotherapy. Previous therapy should have included an anthracycline unless clinically
contraindicated.
use:
Tykerb was approved by FDA March 13, 2007 and developed by GlaxoSmithKline. It is a recently approved theraypy
indicated in combination with Xeloda® for the treatment of patients with advanced or metastatic breast cancer
whose tumors overexpress HER2 and who have received prior therapy including the following: anthracycline, taxane,
and Herceptin® .
Gleevec was developed by Novartis and was approved in 2001 by the FDA. It was the first of a new class of targeted
cancer therapies for certain types of cancer. Gleevec is targeted therapy for treating chronic myelogenous leukemia
(CML), gastrointestinal stromal tumor (GIST), and other malignancies. In particular, it targets, and turns off (inhibits),
specific proteins in cancer cells that prevent cancer cells from growing and multiplying.
Abraxane was approved by the FDA on January 7, 2005 and was developed by AM Bioscience. It is an intended
therapy for breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6
months of adjuvant chemotherapy. Previous therapy should have included an anthracycline unless clinically
contraindicated.
